Artwork

SupChina에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 SupChina 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!

Ep. 64: Telemedicine in China in the time of COVID-19: Part 2

38:23
 
공유
 

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on November 15, 2021 22:04 (2+ y ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Manage episode 274619670 series 2807664
SupChina에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 SupChina 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Episode 64 of Tech Buzz China is the second of two episodes on the Chinese telemedicine sector, which is closely watched in the wake of COVID-19. This week, on the heels of episode 63’s discussion of Ping An Good Doctor, co-hosts Rui Ma and Ying-Ying Lu talk about other experiments, such as Chunyu Yisheng 春雨医生, WeDoctor 好大夫, and Dingxiangyuan 丁香园. We also give overviews of telemedicine efforts by some of the large internet companies, including Alibaba, Baidu, and JD Health.

The overarching story is that healthcare tech is a clear market opportunity in China, and within the narrow space of telemedicine, there are a lot of companies trying to solve the same set of problems. Listen to find out: How did these players all converge on telemedicine, and what are the factors — some currently missing — that must be in place to drive a serious uptick in adoption?

You can find these stories and more at pandaily.com. If you enjoy our content, please do let us know by leaving us an iTunes review, and tweeting at us at @techbuzzchina. We also read your emails, at rui@techbuzzchina.com and ying@techbuzzchina.com. You can also subscribe to our Extra Buzz newsletter on our new website, techbuzzchina.com. As always, thank you for your support.

We are grateful for our talented producers, Caiwei Chen and Kaiser Kuo. Stay healthy, everyone!

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

  continue reading

84 에피소드

Artwork
icon공유
 

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on November 15, 2021 22:04 (2+ y ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Manage episode 274619670 series 2807664
SupChina에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 SupChina 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Episode 64 of Tech Buzz China is the second of two episodes on the Chinese telemedicine sector, which is closely watched in the wake of COVID-19. This week, on the heels of episode 63’s discussion of Ping An Good Doctor, co-hosts Rui Ma and Ying-Ying Lu talk about other experiments, such as Chunyu Yisheng 春雨医生, WeDoctor 好大夫, and Dingxiangyuan 丁香园. We also give overviews of telemedicine efforts by some of the large internet companies, including Alibaba, Baidu, and JD Health.

The overarching story is that healthcare tech is a clear market opportunity in China, and within the narrow space of telemedicine, there are a lot of companies trying to solve the same set of problems. Listen to find out: How did these players all converge on telemedicine, and what are the factors — some currently missing — that must be in place to drive a serious uptick in adoption?

You can find these stories and more at pandaily.com. If you enjoy our content, please do let us know by leaving us an iTunes review, and tweeting at us at @techbuzzchina. We also read your emails, at rui@techbuzzchina.com and ying@techbuzzchina.com. You can also subscribe to our Extra Buzz newsletter on our new website, techbuzzchina.com. As always, thank you for your support.

We are grateful for our talented producers, Caiwei Chen and Kaiser Kuo. Stay healthy, everyone!

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

  continue reading

84 에피소드

Alle afleveringen

×
 
Loading …

플레이어 FM에 오신것을 환영합니다!

플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.

 

빠른 참조 가이드